Literature DB >> 2962972

Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. I. Taxonomy of the producing organism, isolation and biological properties.

T Kameyama1, A Takahashi, S Kurasawa, M Ishizuka, Y Okami, T Takeuchi, H Umezawa.   

Abstract

Alteromonas haloplanktis strain SB-1123 isolated from deep-sea mud produced a new siderophore, bisucaberin. Bisucaberin rendered tumor cells susceptible to cytolysis mediated by murine peritoneal macrophages which were elicited by Proteose peptone and not yet activated by lymphokine. Bisucaberin exerted its sensitizing activity by both the preincubation with tumor cells and the addition to co-culture of macrophages and tumor cells. The activity of bisucaberin was specifically inhibited by ferric ion. Bisucaberin showed direct cytostasis for tumor cells but did not cause cytolysis in the absence of macrophages. Cytostasis by bisucaberin was attributable to the specific inhibition of DNA synthesis in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962972     DOI: 10.7164/antibiotics.40.1664

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  19 in total

1.  Production of desferrioxamine E and new analogues by directed fermentation and feeding fermentation.

Authors:  J Meiwes; H P Fiedler; H Zähner; S Konetschny-Rapp; G Jung
Journal:  Appl Microbiol Biotechnol       Date:  1990-02       Impact factor: 4.813

2.  Promiscuous Enzymes Cause Biosynthesis of Diverse Siderophores in Shewanella oneidensis.

Authors:  Sijing Wang; Huihui Liang; Lulu Liu; Xinhang Jiang; Shihua Wu; Haichun Gao
Journal:  Appl Environ Microbiol       Date:  2020-03-18       Impact factor: 4.792

Review 3.  The chemical biology and coordination chemistry of putrebactin, avaroferrin, bisucaberin, and alcaligin.

Authors:  Rachel Codd; Cho Zin Soe; Amalie A H Pakchung; Athavan Sresutharsan; Christopher J M Brown; William Tieu
Journal:  J Biol Inorg Chem       Date:  2018-06-26       Impact factor: 3.358

4.  Purification, spectroscopic analysis and biological activity of the macrocyclic dihydroxamate siderophore alcaligin produced by Bordetella pertussis and Bordetella bronchiseptica.

Authors:  T J Brickman; J G Hansel; M J Miller; S K Armstrong
Journal:  Biometals       Date:  1996-04       Impact factor: 2.949

5.  Isolation of marine bacteria by in situ culture on media-supplemented polyurethane foam.

Authors:  Mina Yasumoto-Hirose; Miyuki Nishijima; Metiek Kimie Ngirchechol; Kaneo Kanoh; Yoshikazu Shizuri; Wataru Miki
Journal:  Mar Biotechnol (NY)       Date:  2006-04-26       Impact factor: 3.619

6.  The ornithine decarboxylase gene odc is required for alcaligin siderophore biosynthesis in Bordetella spp.: putrescine is a precursor of alcaligin.

Authors:  T J Brickman; S K Armstrong
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

7.  Complexes formed in solution between vanadium(IV)/(V) and the cyclic dihydroxamic acid putrebactin or linear suberodihydroxamic acid.

Authors:  Amalie A H Pakchung; Cho Zin Soe; Tulip Lifa; Rachel Codd
Journal:  Inorg Chem       Date:  2011-05-31       Impact factor: 5.165

Review 8.  Production of bioactive secondary metabolites by marine vibrionaceae.

Authors:  Maria Mansson; Lone Gram; Thomas O Larsen
Journal:  Mar Drugs       Date:  2011-08-25       Impact factor: 6.085

9.  Cytotoxic and apoptotic evaluations of marine bacteria isolated from brine-seawater interface of the Red Sea.

Authors:  Sunil Sagar; Luke Esau; Tyas Hikmawan; Andre Antunes; Karie Holtermann; Ulrich Stingl; Vladimir B Bajic; Mandeep Kaur
Journal:  BMC Complement Altern Med       Date:  2013-02-06       Impact factor: 3.659

10.  Induction of apoptosis in cancer cell lines by the Red Sea brine pool bacterial extracts.

Authors:  Sunil Sagar; Luke Esau; Karie Holtermann; Tyas Hikmawan; Guishan Zhang; Ulrich Stingl; Vladimir B Bajic; Mandeep Kaur
Journal:  BMC Complement Altern Med       Date:  2013-12-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.